The Daily Folgen

For the folk duo Gillian Welch and David Rawlings, pandemic isolation brought about a creative boon. In a year that has been defined by uncertainty, they have returned to what they know: songs about the slow, challenging, beautiful heat of living.This story was written by Hanif Abdurraqib and recorded by Audm. To hear more audio stories from publishers like The New York Times, download Audm for iPhone or Android. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

Maggie Haberman on why the traditional transfer of power is not happening this year, and the implications of that delay. Guest: Maggie Haberman, a White House correspondent for The New York Times For more information on today’s episode, visit nytimes.com/thedaily Background reading: Days after President-elect Joseph R. Biden Jr. was declared the winner of the election, President Trump has still refused to concede.Advisers to the president say Mr. Trump is seeing how far he can push his case and ensure the continued support of his Republican base.A number of leading Republicans have rallied around the president, declining to challenge the false narrative that it was stolen from him. Instead, senators have tiptoed around the reality of Mr. Trump’s loss, and the lack of evidence to suggest widespread election fraud or improprieties that could reverse that result. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

It’s a dark time in the struggle with the coronavirus, particularly in the United States, where infections and hospitalizations have surged.But amid the gloom comes some light: A trial by the drug maker Pfizer has returned preliminary results suggesting that its vaccine is 90 percent effective in preventing Covid-19.With the virus raging, how strong is this new ray of hope?Guest: Carl Zimmer, a science writer and author of the “Matter” column for The New York Times.Background reading: Pfizer has announced positive early results from its coronavirus vaccine trial, cementing the lead in a frenzied global race that has unfolded at record-breaking speed.Meet the couple behind the German company, BioNTech, that partnered with Pfizer to develop the vaccine.We want to hear from you. Fill out our survey about this show and others at nytimes.com/thedailysurvey. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.